News

< Back

Experts in the News: Mark Lachs, S. Jay Olshansky, and Thomas Perls on exceptional longevity in The Hill

Experts in the News: Mark Lachs, S. Jay Olshansky, and Thomas Perls on exceptional longevity in The Hill

On February 7, 2023, The Hill featured insights from AFAR Board Members Mark S. Lachs, MD, and S. Jay Olshansky, PhD, as well as AFAR Beeson scholar Thomas Perls, MD, MPH, on why there has been an increase in the number of older adults today, and why the population of centenarians has grown.

This increase in the older adult population, particularly among those with exceptional longevity, is the driving factor behind AFAR’s SuperAgers Initiative, which aims to provide a basis for understanding the biological and genetic underpinnings of exceptional longevity by studying individuals over the age of 95.

Dr. Lachs is the Immediate Past President of AFAR’s Board of Directors, a 1995 Paul B. Beeson Emerging Leaders Career Development Award in Aging recipient, and a 2017 Irving S. Wright Award of Distinction recipient. He is also the Director of Geriatrics for The New York Presbyterian Health Care System, as well as the Co-Chief of Geriatrics and Palliative Medicine and the Irene and Roy Psaty Distinguished Professor of Medicine at the Weill Cornell Medical College.

Dr. Olshansky is an AFAR Board Member and 2016 Irving S. Wright Award of Distinction recipient. He is currently a Professor in the School of Public Health at the University of Illinois at Chicago, a Research Associate at the Center on Aging at the University of Chicago and at the London School of Hygiene and Tropical Medicine, and the Chief Scientist at Lapetus Solutions, Inc.

Dr. Perls is a 1998 Paul B. Beeson Emerging Leaders Career Development Award recipient. He is the Founder and Director of the New England Centenarian Study and a Professor of Medicine at Boston University’s School of Medicine. Dr. Perls is also the Co-Investigator of the SuperAgers Family Study, part of the SuperAgers Initiative

Read the article, “More People Are Living to be 100; Here’s Why,” here.

Learn more about the SuperAgers Initiative here.

More Recent News

View All News >
AFAR in the News: FAST Biomarkers Initiative advances as part of federal ARPA-H’s PROSPR Program
AFAR in the News: FAST Biomarkers Initiative advances as part of federal ARPA-H’s PROSPR Program
AFAR News: Michael Bass and Shelley Diamond elected to Board of Directors
AFAR News: Michael Bass and Shelley Diamond elected to Board of Directors
AFAR Expert in the News: Scholar-in-Residence Raiany Romanni-Klein, PhD, discusses socioeconomic impact of extending healthspan on the Aging Well Podcast
AFAR Expert in the News: Scholar-in-Residence Raiany Romanni-Klein, PhD, discusses socioeconomic impact of extending healthspan on the Aging Well Podcast
AFAR Experts in the News: Scientific Director Steven N. Austad, PhD, and grantee Vera Gorbudova, PhD, on Long-Living Animals in The Washington Post
AFAR Experts in the News: Scientific Director Steven N. Austad, PhD, and grantee Vera Gorbudova, PhD, on Long-Living Animals in The Washington Post
AFAR Grantees in the News: New research co-authored by Grantees Andrea Francesca Salvador, PhD, and Christoph Thaiss, PhD, on the possible gut–brain connection driving age-related memory loss published in Nature
AFAR Grantees in the News: New research co-authored by Grantees Andrea Francesca Salvador, PhD, and Christoph Thaiss, PhD, on the possible gut–brain connection driving age-related memory loss published in Nature
Los Angeles Times spotlights the Field of Geroscience
Los Angeles Times spotlights the Field of Geroscience
In Memoriam: Richard Menschel
In Memoriam: Richard Menschel
AFAR Leadership in the News: Scientific Director Steven N. Austad, PhD, featured on The Dan Buettner Podcast
AFAR Leadership in the News: Scientific Director Steven N. Austad, PhD, featured on The Dan Buettner Podcast
AFAR Board Members in the News: Nir Barzilai, MD, and Mark Lachs, MD, on therapeutics to extend healthspan in Men’s Health feature on longevity tech
AFAR Board Members in the News: Nir Barzilai, MD, and Mark Lachs, MD, on therapeutics to extend healthspan in Men’s Health feature on longevity tech